The five-year grant was awarded to lead researcher, Lara Jehi, MD, to develop an epilepsy surgery nomogram, a comprehensive risk calculator, to predict which patients would see a positive outcome from the procedure.
Cleveland Clinic Neurological Institute’s Epilepsy Center and Cleveland Clinic Lerner Research Institute’s quantitative health sciences team will collaborate with Rochester, Minn.-based Mayo Clinic and University of Campinas in São Paulo, Brazil on the project.
“The nomogram will enable us to bring patient counseling into the 21st century and expand it beyond our best educated opinion to actual science. It will arm physicians with an advanced statistical tool to better select optimal surgical candidates and estimate the likelihood of seizure freedom after epilepsy surgery,” Dr. Jehi said.
More articles on healthcare finance:
Summa Health System to cut 300 jobs due to $60M operating loss
University of Iowa Health Care to stop accepting checks, cash July 1
West Virginia hospital to charge upfront co-pays for non-emergency ER visits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
